Open Access Scientific Papers

Share itShare on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Print this pageEmail this to someone

Please find here a selection of related scientific papers published under Open Access. For Abstracts, and Full Paper please follow corresponding links.

Minimum Information for Tolerogenic Antigen Presenting cells

Edited by AFACTT Consortium (Working Group 1)

Checklist – Minimum Information for Tolerogenic Antigen Presenting cells

Edited by AFACTT Consortium (Working Group 1)

Cell-Based Therapies with T Regulatory Cells

Mateusz Gliwinski , Dorota Iwaszkiewicz-Grzés, Piotr Trzonkowski1

DOI 10.1007/s40259-017-0228-3

Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells

Xuehui He, Ruben L. Smeets, Esther van Rijssen, Annemieke M. H. Boots, Irma Joosten & Hans J. P. M. Koenen

Scientific Reports (, 7:43003 , DOI: 10.1038/srep43003 (February 2017)

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis

Bell GM, Anderson AE, Diboll J, Reece R, Eltherington O, Harry RA, Fouweather T, MacDonald C, Chadwick T, McColl E, Dunn J, Dickinson AM, Hilkens CM, Isaacs JD.

Annals of the Rheumatic Diseases, 2017 Jan ; 76(1):227-234. doi: 10.1136/annrheumdis-2015- 208456. PMID: 27117700

Factors affecting long‑term efficacy of T regulatory cell‑based therapy in type 1 diabetes

Marek‑Trzonkowska et al.

Journal of Translational Medicine 2016 14:332 (DOI 10.1186/s12967-016-1090-7)

Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens.

Lee WP, Willekens B, Cras P, Goossens H, Martínez-Cáceres E, Berneman ZN, Cools N.

Journal of Immunology Research 2016; 2016: 5392623. (Sep 2014)

Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies.

Lord P, Spiering R, Aguillon JC, Anderson AE, Appel S, Benitez-Ribas D, Ten Brinke A, Broere F, Cools N, Cuturi MC, Diboll J, Geissler EK, Giannoukakis N, Gregori S, van Ham SM, Lattimer S, Marshall L, Harry RA, Hutchinson JA, Isaacs JD, Joosten I, van Kooten C, Lopez Diaz de Cerio A, Nikolic T, Oral HB, Sofronic-Milosavljevic L, Ritter T, Riquelme P, Thomson AW, Trucco M, Vives-Pi M, Martinez-Caceres EM, Hilkens CM.

PeerJ. 2016 Aug 30;4:e2300.

Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients.

Mansilla MJ, Contreras-Cardone R, Navarro-Barriuso J, Cools N, Berneman Z, Ramo-Tello C, Martínez-Cáceres EM.

Jounal of Neuroinflammation. 2016 May 20;13(1):113.

Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort.

Ten Brinke A, Hilkens CM, Cools N, Geissler EK, Hutchinson JA, Lombardi G, Lord P, Sawitzki B, Trzonkowski P, Van Ham SM, Martinez-Caceres EM.

Mediators Inflamm. 2015;2015:471719

Beneficial effect of tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitis.

Mansilla MJ, Sellès-Moreno C, Fàbregas-Puig S, Amoedo J, Navarro-Barriuso J, Teniente-Serra A, Grau-López L, Ramo-Tello C, Martínez-Cáceres EM.
CNS Neuroscience Therapeutics. 2015 Mar;21(3):222-30.